Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics Inc.
WKN: A3DWU7 / Symbol: ATXI / Name: Avenue Therapeutics / Aktie / Pharmazeutika / Small Cap /
0,11 €
22,82 %
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Ratings data for ATXI provided by MarketBeat
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Ratings data for ATXI provided by MarketBeat
Neueste Beiträge
BMO_Capital_Markets in Canadian Imperial Bank of Commerce diskutieren